Formula Growth’s Idexx Laboratories IDXX Stock Holding History

Formula Growth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-550	Closed	-$133K	–	147
2018 Q3	$133K	Buy	+550	New	+$134K	0.02%	142

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Formula Growth's IDXX Position: Q4 2018 in Review

Formula Growth sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 550 shares — an estimated $133K sold.

Formula Growth first reported a position in IDXX in Q3 2018 and held it in 1 quarter. The position peaked at $133K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

Formula Growth reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
Formula Growth sold 550 Idexx Laboratories shares in Q4 2018, an estimated $133K.
Formula Growth first reported a position in Idexx Laboratories in Q3 2018 and held it in 1 quarter.
Formula Growth's Idexx Laboratories position peaked at $133K in Q3 2018.
670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Formula Growth's 13F filing for Q4 2018, filed 14 Feb 2019.